Prospects of medium specific activity <sup>177</sup>Lu in targeted therapy of prostate cancer using <sup>177</sup>Lu‐labeled PSMA inhibitorSudipta Chakraborty, Ashutosh Dash, Rubel Chakravarty et al.|Journal of Labelled Compounds and Radiopharmaceuticals|2016Cited by 27